Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 22.42 |
|---|---|
| High | 23.70 |
| Low | 21.76 |
| Bid | 21.69 |
| Offer | 34.68 |
| Previous close | 22.45 |
| Average volume | 66.73k |
|---|---|
| Shares outstanding | 8.58m |
| Free float | 8.46m |
| P/E (TTM) | -- |
| Market cap | 192.53m USD |
| EPS (TTM) | -0.9346 USD |
Data delayed at least 15 minutes, as of Mar 11 2026 20:00 BST.
More ▼
- Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
- Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
- Sanuwave Announces Q3 FY2025 Financial Results
- Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
- CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
- Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
- Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
- Sanuwave Announces Q2 FY2025 Financial Results
- Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
More ▼
